Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / equity
-
Shares outstanding
-
106M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1.64M
-
Shares change
-
-66.8K
-
Total reported value, excl. options
-
$7.7M
-
Value change
-
-$314K
-
Number of sells
-
-1
-
Price
-
$4.70
Significant Holders of MAXCYTE, INC. - equity (MXCT) as of Q4 2023
2 filings reported holding MXCT - MAXCYTE, INC. - equity as of Q4 2023.
MAXCYTE, INC. - equity (MXCT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.64M shares
of 106M outstanding shares and own 1.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.34M shares), CADIAN CAPITAL MANAGEMENT, LP (5.64M shares), VANGUARD GROUP INC (5.28M shares), Vitruvian Partners LLP (5.04M shares), MILLENNIUM MANAGEMENT LLC (5.01M shares), MORGAN STANLEY (3.48M shares), FMR LLC (2.83M shares), Portolan Capital Management, LLC (2.76M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.54M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.1M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.